Skip to content

FreeDom: Innovative Strategy for the Management of COPD Exacerbations

FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03396172
Enrollment
100
Registered
2018-01-10
Start date
2018-05-24
Completion date
2025-12-31
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation, Oxygen Deficiency

Keywords

COPD, Homecare, Oxygen, Telemedicine, Automated oxygen adjustment, Rehabilitation program

Brief summary

The main objective of the study is to assess the FreeDom innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.

Detailed description

The main objective of the study is to assess the FreeDom innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy will enable an early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation. The main hypothesis of this study is that a strategy for an early return home with a home hospitalization managed by telemedicine will reduce the length of hospitalization by 50 percent from 30 days.

Interventions

OTHERControl

The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria

DEVICEFreeDom

Early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients hospitalized for COPD exacerbation for less than 48 hours will be considered. * known or suspected COPD to entry * Age \> or = 40 years * Ex-smoker history (10 pack / year or more) * Acute Exacerbation: dyspnea of recent onset (less than 15 days) * The need for oxygen therapy with a moderate rate: \<6L / min to maintain SpO2 \> 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home)

Exclusion criteria

* Refusal to consent to participate in the study, * Indication for an imminent intubation according to the pulmonologist, * Sleep Apnea * NIV used at home * Lack of FreeO2 system available at the time of randomization * Non-autonomous and alone at home * Patient alone at home * Patients who live more than 50 km from the hospital * Patient already included in the study within 3 months

Design outcomes

Primary

MeasureTime frameDescription
The number of hospital days during COPD exacerbation at day 30.30 daysThe objective of the study is to reduced the hospitalisation days by 50 % at day 30 during COPD exacerbation

Secondary

MeasureTime frameDescription
Rate of Emergency consultation and hospital readmission1 and 3 monthsRate of Emergency consultation and hospital readmission
Health Related Quality of Life1 and 3 monthsSurvey of health related quality of life
Cost of care at 3 months3 monthsEconomic evaluation about these 2 different strategy of COPD exacerbation management using micro-costing approach and including the cost of the FreeO2 technology
Oxygenation data (% of time in the SpO2 target, % of time with hypoxemia, % of time with hyperoxia)From inclusion to hospital discharge and from hospital discharge to the end of oxygen therapy (around one week after discharge)The continuous measurement of SpO2 and O2 flow rate with the FreeO2 device (only in the FreeDom strategy) will allow the calculation of the % of time within the SpO2 target (recorded in the FreeO2) ± 2%, with hypoxemia (% of time with SpO2 \< 85%) and with hyperoxia (% of time above SpO2 target +5%)
Number of consultations3 monthsNumber of consultation : phone call, video consultation, rehabilitation, home visit

Countries

Canada

Contacts

Primary ContactFrançois Lellouche
francois.lellouche@criucpq.ulaval.ca418-656-8711
Backup ContactPierre-alexandre Bouchard
pierre-alexandre.bouchard@criucpq.ulaval.ca418-656-8711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026